Plasma membrane signaling often requires the recruitment of cytosolic enzymes such as kinases, phosphatases and hydrolases. Most pathways utilize inducible binding to membrane proteins by exposing or creating interaction motifs through conformational changes or posttranslational modifications. Cytosolic enzymes frequently assume autoinhibited conformations and become active only after binding to a receptor. Despite their universal presence, possible regulatory functions of assembly dynamics have been overlooked. This is most likely because previous approaches were limited by the speed of individual events and a lack of structural information. We chose T cell activation as a model system to investigate whether conformation-dependent receptorinteraction dynamics control catalytic activities. The T cell receptor (TCR)-associated kinase Zap70 is a typical example of an inactive cytosolic tyrosine kinase that is recruited to a transmembrane receptor lacking intrinsic catalytic activity [1] [2] [3] [4] [5] [6] [7] . Zap70 and the related tyrosine kinase Syk 8 are central to all cellular immune responses. They associate with numerous surface receptors, including TCRs, B cell receptors, Fc receptors and integrin receptors. TCR signaling is initiated by the recognition of a peptide presenting major histocompatibility complexes (pMHC) on antigen-presenting cells 9 . The tyrosine kinase Lck is recruited to the TCR through its association with the coreceptors CD4 and CD8, which also bind pMHC 10 . Lck is activated by transautophosphorylation and in turn phosphorylates the immunoreceptor tyrosine-based activation motifs (ITAMs) of the TCR-CD3 complex 11 . Zap70 is recruited to the doubly phosphorylated ITAMs (p-ITAMs) of the TCR via its SH2 domains 12 . CD3-bound Zap70 is activated by both Lck and trans-autophosphorylation 13, 14 . Zap70 then phosphorylates its downstream substrates, including the adaptor protein LAT 15 .
Plasma membrane signaling often requires the recruitment of cytosolic enzymes such as kinases, phosphatases and hydrolases. Most pathways utilize inducible binding to membrane proteins by exposing or creating interaction motifs through conformational changes or posttranslational modifications. Cytosolic enzymes frequently assume autoinhibited conformations and become active only after binding to a receptor. Despite their universal presence, possible regulatory functions of assembly dynamics have been overlooked. This is most likely because previous approaches were limited by the speed of individual events and a lack of structural information. We chose T cell activation as a model system to investigate whether conformation-dependent receptorinteraction dynamics control catalytic activities. The T cell receptor (TCR)-associated kinase Zap70 is a typical example of an inactive cytosolic tyrosine kinase that is recruited to a transmembrane receptor lacking intrinsic catalytic activity [1] [2] [3] [4] [5] [6] [7] . Zap70 and the related tyrosine kinase Syk 8 are central to all cellular immune responses. They associate with numerous surface receptors, including TCRs, B cell receptors, Fc receptors and integrin receptors. TCR signaling is initiated by the recognition of a peptide presenting major histocompatibility complexes (pMHC) on antigen-presenting cells 9 . The tyrosine kinase Lck is recruited to the TCR through its association with the coreceptors CD4 and CD8, which also bind pMHC 10 . Lck is activated by transautophosphorylation and in turn phosphorylates the immunoreceptor tyrosine-based activation motifs (ITAMs) of the TCR-CD3 complex 11 . Zap70 is recruited to the doubly phosphorylated ITAMs (p-ITAMs) of the TCR via its SH2 domains 12 . CD3-bound Zap70 is activated by both Lck and trans-autophosphorylation 13, 14 . Zap70 then phosphorylates its downstream substrates, including the adaptor protein LAT 15 .
The Zap70 tandem SH2 domain module (tSH2) consists of an N-terminal SH2 domain, interdomain A (I-A) and a C-terminal SH2 domain 6, 7, 16, 17 . Interdomain B (I-B) connects the tSH2 and the kinase domain (KinD). Previous structural analyses showed that the tyrosine residues Y315 and Y319 in I-B cause a closed or autoinhibited conformation of Zap70 by binding specific pockets within I-A and the KinD, respectively 6, 7, 16, 17 . This autoinhibited conformation has been thought to render Zap70 catalytically inactive. Binding of Zap70 to the TCR is thought to loosen the I-A-KinD interaction 17 , thus facilitating phosphorylation of Y315 and Y319 by either Lck 14, 18 or trans-autophosphorylation 13 . Mutation of Y315 and Y319 in Zap70 to phenylalanine or alanine prevents appropriate T cell activation 13, 14, [17] [18] [19] [20] [21] [22] [23] . Phosphorylation of the tyrosine residues Y492 and Y493 in the activation loop of the KinD of Zap70 by either Lck or trans-autophosphorylation controls the catalytic activity of TCR-bound Zap70 (refs. 18,24-26) .
We used hydrogen-deuterium exchange mass spectrometry (HDX-MS) 27 to investigate the structure of p-ITAM-associated and/or phosphorylated Zap70. Our data showed that TCR binding and/or phosphorylation induced an open conformation in Zap70. We used Zap70 mutants that were either preferentially in the closed conformation or constitutively in the open conformation to show that the different conformations control TCR binding kinetics but not the intrinsic catalytic activity of Zap70. Because of the very short receptor dwell times, corecruitment of Lck to the TCR complex is required to phosphorylate Zap70 and stabilize its association to p-ITAMs. Our findings show that Zap70 activity is controlled by a kinetic proofreading mechanism. 9 6 2 VOLUME 16 NUMBER 9 SEPTEMBER 2015 nature immunology A r t i c l e s RESULTS
HDX-MS reveals conformational changes in Zap70
We used HDX-MS to detect conformational changes in Zap70 after binding to p-ITAMs of the TCR. With this method, amide hydrogens in Zap70's amino acid backbone (Fig. 1a) are replaced with deuterium by transfer of recombinant Zap70 proteins into heavy water (D 2 O)-based solution. MS of subsequent pepsin digests allows for the quantification and assignment of HDX to specific amino acid sequences. HDX rates are influenced by solvent exposure and hydrogen bonds. Changes in HDX patterns can be used to determine the locations of conformational changes, post-translational modifications and/or intra-and intermolecular interaction sites induced by complex formation (Fig. 1b-e) . Thus, HDX-MS can provide structural insights on different activation states of soluble Zap70. However, HDX-MS does not generate an actual structure and has lower resolution than crystallography. In this study we used Y315 and Y319 mutants (Fig. 1a) in I-B, and we refer to the wild-type Zap70 here as YY. HDX-MS was done with recombinant Zap70 with asparagine instead of aspartic acid at position 461 (D461N, referred to herein as YY DN ). This mutation renders Zap70 catalytically inactive or 'kinase dead' . In the data analyses, HDX rates from YY DN alone were used as references for normalizing all other HDX-MS data. Differences in HDX rates between YY DN and other forms of Zap70 were colorcoded and either projected onto the published autoinhibited structure of YY DN 17 ( Fig. 2 and Supplementary Fig. 1 ) or compared by sequence alignment of different Zap70 forms ( Supplementary  Fig. 2) . We compared the HDX rates of YY DN alone with those of YY DN in complex with the phosphorylated cytosolic domain of the TCR CD3γ chain, p-CD3γ CD (referred to here as YY DN cplx ). Reduced HDX rates of YY DN in comparison with rates for YY DN cplx were observed at the contact sites between the p-ITAM and the tSH2 (E174-F187, I203-L212 and L239-L250) ( Fig. 2a and Supplementary Fig. 2 ). Increased HDX rates in I-A (D116-L152), I-B (K251-L287) and the KinD (Y598-L600) of YY DN cplx compared with those for YY DN alone indicated the separation of I-A and KinD upon p-CD3γ CD binding ( Fig. 2a and Supplementary Fig. 2 ). We observed no changes in the HDX rates in the Y319-binding pocket of the N-terminal lobe of the KinD ( Fig. 2a and Supplementary Fig. 2 ), which suggested that that the interaction between I-B and KinD was maintained upon Zap70 binding to p-CD3γ CD . Reduced HDX rates were observed in the Nterminal lobe (G350-V356, I368-M383) and C-terminal lobe (L469, Y535-L568) of the KinD (Fig. 2a and Supplementary Fig. 2 ), which indicated additional conformational changes. These data show that p-CD3γ CD binding was sufficient to induce the open conformation of Zap70 by separation of I-A and KinD, as well as conformational changes in KinD (Supplementary Fig. 3a) .
On the basis of the crystal structure of autoinhibited Zap70, it has been proposed that phosphorylation of Y315 and Y319 induces an open conformation and consequently catalytic activity of Zap70 (refs. 16,17) . We analyzed HDX rates of phosphorylated YY DN (p-YY DN ). Immunoblotting for phosphorylation of Y292, Y319, Y492 and Y493 as well as for total tyrosine phosphorylation showed that all recombinant forms of Zap70 were purified as nonphosphorylated and were phosphorylated after incubation with recombinant Lck (Supplementary Fig. 4) . Furthermore, MS analyses did not detect any nonphosphorylated Zap70 peptides containing Y292, Y315, Y319, Y492 and Y493, which indicated efficient phosphorylation of Zap70 by Lck (results not shown). Compared with YY DN , p-YY DN showed increased HDX rates in I-A (D116-L152) and I-B (Y315-L332) ( Fig. 2a and Supplementary Fig. 2) , which indicated that phosphorylation of Y315 and Y319 separated I-A and KinD ( Supplementary  Fig. 3b ). Additional HDX rate increases in I-B (Y315-L332) and the 
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A r t i c l e s N-terminal lobe of the KinD (R359-D365) indicated the dissociation of Y319 from its binding pocket in the KinD ( Fig. 2a and Supplementary Fig. 2 ). To exclude the possibility that Zap70 phosphorylation outside of I-B can induce an open conformation, we carried out HDX-MS analyses with a Zap70 mutant in which phenylalanine replaced tyrosine residues Y315 and Y319 (referred to here as FF DN ). These mutations have been shown to prevent T cell activation upon TCR stimulation 17, 18, 23 . In comparison with those for YY DN , HDX rates for nonphosphorylated FF DN were reduced in I-A (D116-L118, Y126-G135 and E139-L152), I-B (N288-T312)  and the KinD (M384-Q388, T494-C510, E531-L568 and Y598-L600) ( Fig. 2b and Supplementary Fig. 2 ). Because HDX-MS also detects shifts in the equilibrium of distinct protein conformations 28 DN cplx were increased in I-A (E136-A137 and I142-L152) and I-B (K251-A267 and N288-T312) ( Fig. 2b and Supplementary Fig. 2 Figs. 1 and 2) .
Previous reports have shown that a Zap70 mutant in which Y315 and Y319 are replaced by alanine (referred to here as AA DN ) has reduced activity in T cells but increased activity in TCR-independent activation systems 17, 18, 23 . The HDX rates in I-A and I-B of AA DN were the highest observed compared with those of YY DN , including in regions of I-B and the KinD that were not detected in any other form of Zap70 (K333-L338, I342-M359, I368-E382, R385-Q388, L412-M414, S483-Y492 and A601-G606) ( Fig. 2c and Supplementary  Fig. 2 ). AA DN binding to p-CD3γ CD (AA DN cplx ) and/or phosphorylation of AA DN by Lck (p-AA DN ) slightly reversed the effects of the alanine mutations on HDX rates ( Fig. 2c and Supplementary Figs. 1 and 2) . In AA DN , p-AA DN and AA DN cplx , the Y319 binding site was unoccupied, and no interaction between I-B and KinD was detected ( Fig. 2c and Supplementary Figs. 1 and 2) . These data suggest that (Fig. 2d and Supplementary Figs. 1 and 2) . This is consistent with complete dissociation of I-A and KinD in the open forms of Zap70. In addition, an expected effect of an open conformation is an increased volume, which can be measured by reduced retention times in size-exclusion chromatography. The Zap70 forms that were open according to the HDX-MS analyses had lower retention times than the Zap70 forms determined to be closed ( Fig. 3a-c) . This supports the conclusion that increased HDX rates in I-A and I-B are indeed caused by Zap70 adopting an open conformation.
Although all p-ITAMs of the TCR bind Zap70 with similar binding affinities [29] [30] [31] [32] , it is possible that the conformational changes seen here in response to p-CD3γ CD binding might be specific to the CD3γ subunit of the TCR. Therefore, we carried out HDX-MS on YY DN bound to six phosphorylated peptides comprising the sequences of all TCR ITAMs (i.e., CD3γ, -δ, -ε, -ζ1, -ζ2 and -ζ3). Compared with those in YY DN alone, HDX rates in the I-A region were increased in all YY DN -p-ITAM complexes (Fig. 3d) , which demonstrated that binding to all TCR p-ITAMs causes Zap70 to open via a general mechanism. In addition, we observed reduced retention times for all YY DN -p-ITAM complexes in analytical size-exclusion chromatography ( Fig. 3e) , which indicated an open conformation of Zap70 binding to all TCR p-ITAMs. Taken together, these data show that Zap70 adopts an open conformation after p-ITAM binding, phosphorylation or mutation of Y315 and Y319 to alanine. In addition, whereas AA DN is always open, FF DN is preferentially in a closed conformation.
Conformation does not affect the catalytic activity of Zap70
Multiple reports have shown that mutations of the Y315 and Y319 residues affect TCR signal transduction 17, 18, 23 . The phenylalanine mutant transduces TCR signals and triggers T cell activation but has increased background activity and reduced activity upon TCR ligation. In TCR-independent activation systems, this mutant shows higher activity than the wild type. The phenylalanine mutant cannot transduce TCR-induced signals or activate T cells. To study the catalytic activity of Zap70, we analyzed the wild-type form (YY) and Y315F-Y319F and Y315A-Y319A mutants of Zap70 (called FF and AA here). Notably, these forms of Zap70 do not have the D461N mutation and therefore have the potential to become catalytically active. We stably expressed wild-type and mutant Zap70 fused to GFP (referred to here as GFP YY, GFP FF and GFP AA, respectively) in Zap70-deficient Jurkat T cells (P116) and analyzed phosphorylation of Zap70 and the transmembrane signaling protein Lat upon activation with increasing concentrations of stimulatory antibodies. At high antibody concentrations, GFP YY showed phosphorylation of residue Y493 (p-Y493) in the Zap70 activation loop (Fig. 4a) .
In contrast, GFP AA and GFP FF showed little or no increase in amounts of p-Y493. Lat phosphorylation on Y191 (p-Y191), a readout for Zap70 activity, was detected only in P116 cells expressing GFP YY and GFP AA (Fig. 4a) . GFP AA-expressing P116 cells required at least fourfold more stimulatory antibodies than GFP YY-expressing cells did to achieve similar levels of Lat phosphorylation (Fig. 4a) . These data confirm the results of published studies and suggest that the reduced signal transduction of the Y315 and Y319 Zap70 mutants was due to lower amounts of activated Zap70 molecules, and not to the reduced catalytic activity of the mutants. Catalytic activity of Zap70 is reported to require the open conformation [16] [17] [18] 33 . The same studies also suggest that the open conformation of Zap70 (specifically AA) is more susceptible to nonspecific phosphorylation. To avoid any Zap70 background phosphorylation and catalytic activity in our studies, we expressed recombinant YY and AA fused to the phosphatase domain of the tyrosine phosphatase SHP-1 (which was subsequently removed). This approach yielded Zap70 without phosphorylation detectable by immunoblotting ( Supplementary  Fig. 4b ). We used a two-step in vitro kinase assay to quantify the potential of Zap70 to become phosphorylated by Lck on residue Y493, which is a marker of kinase activation, and its catalytic activity toward Lat (total tyrosine phosphorylation). Increasing amounts of Lck phosphorylated Y493 similarly in recombinant YY, FF and AA (Fig. 4b) . Without initial Lck phosphorylation, YY, FF and AA showed no catalytic activity (Fig. 4c) . Even at increased concentrations (up to 1.4 µM), nonphosphorylated YY, FF and AA did not show any catalytic activity (results not shown). These results indicated that the open conformation is not sufficient to induce kinase activity or autophosphorylation of Zap70. All forms of Zap70 showed comparable catalytic activity upon phosphorylation with different amounts of Lck and reached similar maximum activities (Fig. 4c) . Because the HDX-MS data showed that p-FF DN was in the closed conformation, these results suggest that both the closed (autoinhibited) and open conformations of Zap70 have similar potential to become activated, as well as comparable catalytic activity toward their substrates. On the basis of these data, the cellular signaling defects of FF and AA cannot be explained by differences in their catalytic activity.
Zap70 conformation regulates TCR binding dynamics
We next tested the effect of Zap70's conformation on its ability to bind p-ITAMs in ELISA-based competition assays. We monitored the binding of Myc-tagged YY DN We next used biolayer interferometry (BLI) 34 to determine the dissociation constants (K D ) and on and off rates (k on and k off ) for binding of Zap70 to p-CD3γ CD . The curves for binding of YY DN and FF DN to p-CD3γ CD had to be fitted to a 2:1 heterogeneous ligand-binding model yielding two sets of binding constants (Fig. 6a,b Table 2 ). The k on 1 rates of p-CD3γ CD binding for YY DN and FF DN were twice as fast as those for AA DN and tSH2, whereas the k off 1 values for YY DN and FF DN were half those for AA DN and tSH2 ( Fig. 6b and Supplementary Table 2) . The second set of (weaker) p-CD3γ CD -binding constants for YY DN and FF DN showed tenfold higher K D 2 values, due to twofold higher on rates and ~20-fold higher off rates compared with the K D 1 values (Fig. 6b and Supplementary  Table 2 ). The BLI data suggest that the closed conformation of Zap70 causes weaker binding to p-CD3γ CD and that the Y315F-Y319F mutant of Zap70 binds less efficiently because its fraction of molecules in the closed conformation is greater than that for the wild type.
We also tested the effects of We suggest that this lengthened dwell time increases the likelihood that Zap70 will be activated by either CD4-or CD8-associated Lck or another TCR-associated Zap70 molecule.
Zap70 conformations determine dwell time at TCR microclusters
We analyzed Zap70 recruitment to microclusters (MCs) to determine whether the different binding characteristics we observed in vitro exist in vivo. MCs are membrane structures that are formed around ligandengaged TCRs 35, 36 . MCs are crucial for signal initiation and contain most of the signaling molecules involved in early T cell activation. The interaction kinetics between wild-type Zap70 and the TCR were previously studied by fluorescence recovery after photobleaching with confocal microscopy (FRAP Conf ) 35 . In that study, Zap70 showed high rates of exchange with the MCs during early (<5 min) T cell activation and strongly reduced exchange rates at later stages (10-20 min) 35 . Therefore, we used FRAP Conf to analyze early Zap70 recruitment to MCs. We expressed GFP-tagged Zap70 constructs ( GFP YY, GFP FF, GFP AA and GFP tSH2) or GFP-tagged CD3ζ ( GFP CD3ζ) in Zap70-deficient (P116) and wild-type (E6.1) Jurkat T cells. T cells were activated on glass surfaces coated with anti-CD3ε to induce the formation of MCs and to enable determination of the mobile fraction of MC-associated Zap70 or CD3ζ, as well as the halftime of recovery (t 1/2 ). It should be noted that binding to all ten p-ITAMs of the TCR-CD3 complex can contribute to Zap70 clustering. All forms of Zap70 were able to form MCs in Zap70-deficient Jurkat T cells ( Supplementary  Fig. 5a ). However, in E6.1 Jurkat T cells, GFP FF could not compete with endogenous Zap70 for TCR binding (Supplementary Fig. 5a ). Fluorescence recovery of GFP CD3ζ was minimal as a result of TCR immobilization on the antibody surfaces (Fig. 7a,b, Supplementary  Fig. 5b ,c and Supplementary Table 3) . After activation, 80%-90% of the GFP YY was found in the mobile fraction with a t 1/2 of 19 s (Fig. 7a,b, Supplementary Fig. 5b ,c and Supplementary Table 3 ). The mobile fraction of GFP FF was ~100% with a t 1/2 of 14 s in P116 Jurkat T cells (Fig. 7a,b and Supplementary Table 3) , which indicated that it was not able to transition into the open, high-affinity conformation of Zap70 and therefore had higher exchange rates and less stable TCR binding. GFP AA had a mobile fraction of ~50% with a t 1/2 of 28 s (Fig. 7a,b, Supplementary Fig. 5b,c Table 2 ).
The data shown are representative of five independent experiments. npg A r t i c l e s recovery and a t 1/2 of 26 s (Fig. 7a,b, Supplementary Fig. 5b,c We analyzed the Zap70 exchange rates in short-term-cultured primary CD4 + T cells from 5c.c7 TCR transgenic mice. These T cells recognize agonist peptide derived from moth cytochrome c (MCC; amino acids 88-103) presented by MHC class II molecules (specifically, I-E k ). T cells were activated on glass surfaces coated with I-E k -MCC complexes and costimulatory CD80. Because primary T cells have smaller MCs and increased amounts of cytosolic Zap70 relative to Jurkat T cells, we measured the exchange of Zap70 with MCs by FRAP with total internal reflection fluorescence microscopy (FRAP TIRF ). The FRAP TIRF data for primary mouse T cells (Fig. 7c,d and Supplementary Table 3 ) were similar to those for Jurkat T cells and confirmed our earlier findings. The mobile fractions and t 1/2 values for the different Zap70 forms were as follows: GFP YY, ~80%, 11 s; GFP FF, ~75%, 3.5 s; GFP AA, ~45%, 9 s; and GFP tSH2, ~60%, 11 s (Fig. 7c,d and Supplementary Table 3) . Compared with the activity of wild-type Zap70, the absent and reduced cellular activities of the Y315F-Y319F and Y315A-Y319A Zap70 mutants after TCR ligation suggested an optimized TCR dwell time and phosphorylation sequence for Zap70 to achieve maximal kinase and cellular activity. Overall our findings support the idea of a kinetic proofreading mechanism for the control of Zap70 activity (Supplementary Fig. 6 ). We propose a kinetic proofreading mechanism for Zap70 activation based on multiple conformational and receptor-binding equilibria. In quiescent T cells, Zap70 is cytosolic and inactive but has optimal TCR binding potential. Upon TCR association Zap70 assumes an open conformation, but its propensity for the closed conformation results in short receptor dwell times. Consequently, the probability of Zap70 phosphorylation and activation is low. T cell recognition of peptide MHCs and the corecruitment of coreceptorbound Lck increase the probability of Zap70 phosphorylation. Lck corecruitment itself is controlled by antigen dwell times with the TCR and the fraction of coreceptors coupled with active Lck 37 
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A r t i c l e s T cell activation 11, 38, 39 . Our data suggest that short TCR dwell times of Zap70 maintain T cells in a quiescent state despite this background stimulation by minimizing the chances that Zap70 will encounter active kinases. In contrast, stabilization of TCR binding upon T cell activation results in a 'switch-like' response. Trans-autophosphorylation 13 increases the amount of Zap70 stably bound to TCR clusters and amplifies the signal. This mechanism creates an activation window that prevents responses to weak or endogenous ligands and therefore precludes hyperactivation and autoimmune responses. However, this mechanism also allows for the recognition of a small number of antigenic ligands that could potentially initiate appropriate immune responses.
Described advantages of enzyme recruitment to receptors that lack intrinsic catalytic activity include variable assembly of distinct complexes, separation of catalytic activity from substrates and control over local concentrations of signaling molecules. Here we have shown that the dynamic and flexible nature of these interactions makes the recruitment event itself an essential component of the activation mechanism. We suggest that our findings have broad implications for cellular pathways that utilize SH2 domains 40 . These include pathways used for signal transduction, cytoskeletal regulation, transcription and protein degradation. Moreover, paired SH2 domains, as studied here, can be found in many enzyme types, such as kinases (e.g., Zap70 and Syk), phosphatases (e.g., SHP-2), hydrolases (e.g., PLCγ) and transcription factors (e.g., Spt6). More generally, any protein-interaction domain with specificity for protein motifs, post-translational modifications, nucleic acids or lipids 41 has the potential to be involved in similar mechanisms. Considering all of our findings, we suggest that the control of enzymatic activity through recruitment dynamics and their modulation is likely to be a common mechanism in biology.
METHODS
Methods and any associated references are available in the online version of the paper.
ONLINE METHODS
Expression and purification of Zap70 proteins, ∆N-Lck, CD3γ CD and Lat. Baculovirus expression. Wild-type and mutant Zap70 proteins were produced in insect cells with the Bac-to-Bac Baculovirus Expression System (Invitrogen). Full-length wild-type human Zap70 (YY) and mutant forms YY DN (D461N), FF DN (Y315F, Y319F and D461N), AA DN (Y315A, Y319A and D461N), FF (Y315F and Y319F) and AA (Y315A and Y319A) were cloned into pFastBac Vector (Invitrogen). All constructs had a C-terminal linker (GAS) and a human rhinovirus (HRV) 3C protease cleavage site (LEVLFQGP) followed by a glycine serine linker (GGGS) and a 12-His tag. Mutations in YY were introduced by site-directed mutagenesis and confirmed by DNA sequencing. To prevent autophosphorylation, we cloned YY and AA with a C-terminally fused human SHP-1 phosphatase domain (amino acids 265-522) between the glycine serine linker and the 12-His tag. In addition, we cloned YY DN expressed with a C-terminal tag for detection by placing a Myc tag (EQKLISEFELN) ( Myc YY DN ) between Zap70 and the HRV 3C protease cleavage site. Baculovirus stock was made according to the Bac-to-Bac manufacturer's protocol. Recombinant bacmid DNA was isolated from transfected DH10bac cells by maxi-prep DNA purification (Invitrogen), and bacmids were screened by blue/white selection and subsequent PCR. Sf9 insect cells were transfected with Cellfectin II reagent according to the manufacturer's manual for obtaining viral stock. We amplified baculovirus by infecting Sf9 cells with 1:2,000 viral stock at 27 °C in Sf900 media (Invitrogen) supplemented with 10% FCS (HiClone), 1× pen-strep, 2× glutamine, Fungizone 1:400 by maintaining the cell number at 2 × 10 6 per milliliter and collecting virus at 50% cell death. The viral titer was individually optimized by small-scale Zap70 expression analysis (48 h post-infection) with Hi5 insect cells in protein expression media (Sf900/Insect Express (Lonza) (1:3 ratio) supplemented with 1× pen-strep, 2× glutamine, Fungizone 1:400). All insect cell cultures were grown at 27 °C.
Zap70 expression, purification and phosphorylation. For preparative scale expression, 2 × 10 6 Hi5 cells per milliliter were infected with P1 viral stocks at dilutions ranging from 1:100 to 1:500 and grown at 27 °C for 64 h with agitation (125 rpm). Cells were collected by centrifugation (1,800g, 15 min) . We treated active kinases (YY, FF and AA) with kinase inhibitors by suspending cells in 1/10 of the original culture volume in media containing 0.5 µM staurosporine, 100 µM genistein and incubating them for 30 min at 27 °C with agitation (125 rpm) before collecting them by centrifugation. Cells were lysed at 4 °C for 30 min in 100 ml lysis buffer (50 mM HEPES, pH 7.4, 0.5 M NaCl, 10% glycerol, 10 mM MgCl 2 , 1.3% NP-40, 1 mM DTT, 20 mM imidazole, 2 µg/ml leupeptin, 1 µg/ml pepstatin, 0.1 mM PMSF, 0.1 µM staurosporine, 20 µM genistein) per liter of culture volume and stirring. Lysate was cleared by centrifugation at 20,000g for 1 h at 4 °C. Cleared lysate was treated with 10 µg/ml DNAseI (Roche) for 25 min at room temperature (with stirring). Zap70 was purified by binding to nickel-nitrilotriacetic acid (Ni-NTA) agarose beads (Thermo Scientific) overnight at 4 °C. Ni-NTA beads were washed on a gravity flow column with 50 column volumes of wash buffer (50 mM HEPES, pH 7.4, 0.5 M NaCl, 10% glycerol, 0.1% octyl-β-D-glucopyranoside, 1 mM DTT, 50 mM imidazole, 0.05 mM PMSF). Zap70 was subsequently cleaved off the beads in wash buffer (two times the bead volume) with HRV 3C protease (75 µg/ml Ni-NTA beads) at 4 °C overnight. Zap70-containing elution fractions were concentrated and purified by S200 size-exclusion chromatography (SEC) into S200 buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.1% octyl-β-D-glucopyranoside, 10% glycerol, 1 mM Na 3 VO 4 ). Pure Zap70 was dialyzed against S200 buffer supplemented with 50% glycerol and stored at −20 °C. We obtained phosphorylated Zap70 samples by incubating SEC-purified proteins at 1-2 mg/ml at 30 °C for 60 min with 1:4 molar ratio purified ∆N-Lck (expression and purification described later) in S200 buffer supplemented with 5 mM ATP, 25 mM MgCl 2 , 1 mM Na 3 VO 4 . His-tagged ∆N-Lck was removed by incubation with Ni-NTA beads and subsequent purification by SEC. Purified phosphorylated Zap70 was dialyzed against S200 buffer supplemented with 50% glycerol and stored at −20 °C.
∆N-Lck expression and purification. His-tagged ∆N-Lck lacking the first 60 amino acids was purified from baculovirus-transfected insect cells. 2 × 10 6 Hi5 insect cells per milliliter were transfected with 1:200 baculovirus P1 and grown for 64 h in a shaker (27 °C, 125 rpm) . Before being collected, Hi5 cells were treated with 0.4 mM pervanadate for 30 min at 27 °C with agitation (125 rpm) to phosphorylate and activate Lck. We made fresh pervanadate by oxidizing 20 mM Na 3 VO 4 with 1.5% H 2 O 2 at room temperature for 10 min and subsequently removing peroxide by catalase treatment. After collecting cells by centrifugation (1,800g, 15 min), we lysed them in Lck lysis buffer (50 mM HEPES, pH 7.4, 200 mM NaCl, 10% glycerol, 10 mM MgCl 2 , 1.3% NP-40, 1 mM DTT, 20 mM imidazole, 2 µg/ml leupeptin, 1 µg/ml pepstatin, 0.1 mM PMSF, 0.5 mM Na 3 VO 4 ) by suspending them in 1/10 the original culture volume and stirring for 30 min at 4 °C. Lysate was cleared by centrifugation at 20,000g for 1 h at 4 °C. Cleared lysate was treated with 10 µg/ml DNAseI (Roche) for 25 min at room temperature with stirring. ∆N-Lck was purified by binding to Ni-NTA (Thermo Scientific) overnight at 4 °C. Ni-NTA beads were washed on a gravity flow column with 50 column volumes of wash buffer (50 mM HEPES, pH 7.4, 500 mM NaCl, 10% glycerol, 0.1% octyl-β-D-glucopyranoside, 1 mM DTT, 40 mM imidazole, 0.5 mM Na 3 VO 4 , 0.05 mM PMSF), and ∆N-Lck was eluted with wash buffer supplemented with 300 mM imidazole. Fractions containing ∆N-Lck were concentrated and purified by SEC in Lck SEC buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.1% octyl-β-D-glucopyranoside, 10% glycerol, 1 mM Na 3 VO 4 ). Pure ∆N-Lck was dialyzed against SEC buffer supplemented with 50% glycerol and stored at −20 °C.
Escherichia coli expression and purification of tSH2, Myc Lat, CD3γ CD , cys CD3γ CD and GST CD3γ CD . All constructs were cloned into a modified pET30 vector resulting in an N-terminal 12-His tag (MHHHHHHHHHHHHG) followed by GST, a linker (AAGAAG), an HRV 3C protease cleavage site (LEVLFQGP) and another linker (GT) before the target proteins. Human Zap70 1-256 (tSH2); human Myc Lat , which includes an N-terminal Myc tag (EQKLISEFELN) plus a short linker (GT); human CD3γ 137-182 (preceded by GG); and CD3γ 137-182 containing an N-terminal cysteine ( cys CD3γ CD ) were transformed into BL21-DE3 bacteria and grown in TB media with 10 µg/ml kanamycin after 1:20 inoculation from an overnight culture in a shaker (37 °C, 220 rpm). After the culture reached an A 600 of 0.7, we induced expression with 0.5 mM IPTG and allowed cells to grow for 4 h (30 °C, 220 rpm). Cells were collected by centrifugation (4,500g, 15 min, 4 °C). Cells were suspended in lysis buffer (25 mM HEPES, pH 7.4, 300 mM NaCl, 5% glycerol, 20 mM imidazole, 5 mM β-mercaptoethanol, 0.1 mM PMSF) and lysed by three passes through a microfluidizer cell disruptor (Microfluidics). Lysates were cleared by centrifugation (30,000g, 30 min, 4 °C) and purified on Ni-NTA affinity resin. After overnight incubation with Ni-NTA at 4 °C, beads were washed with 50 column volumes of wash buffer (25 mM HEPES, pH 7.4, 300 mM NaCl, 40 mM imidazole, 5% glycerol, 5 mM β-ME) on a gravity flow column. GST CD3γ CD was subsequently eluted with wash buffer supplemented with 375 mM imidazole, concentrated, and purified by S200 SEC (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT, 0.1% octyl-β-Dglucopyranoside, 10% glycerol, 1 mM Na 3 VO 4 ). For tSH2, Myc Lat, CD3γ CD and cys CD3γ CD , proteins were subsequently cleaved off the beads in wash buffer (two times the bead volume) with HRV 3C protease overnight at 4 °C (75 µg/ml of beads). Elution fractions containing tSH2 and Myc Lat were concentrated and purified by S200 SEC. Fractions containing CD3γ CD and cys CD3γ CD were precipitated overnight with eight volumes of −20 °C acetone and then washed extensively with 80% acetone (−20 °C) before being resuspended in a small volume of wash buffer and purified on a Superdex Peptide column. Pure tSH2 and Myc Lat were dialyzed against SEC buffer supplemented with 50% glycerol and stored at −20 °C. Pure GST CD3γ CD , CD3γ CD and cys CD3γ CD were phosphorylated with recombinant Lck as described above. After phosphorylation, GST p-CD3γ CD was further purified at 4 °C overnight on glutathione-agarose affinity resin (Bioworld) to remove Lck. Glutathione beads were washed with 50 column volumes of wash buffer on a gravity column, and bound proteins were eluted with wash buffer supplemented with 10 mM reduced glutathione. GST p-CD3γ CD -containing fractions were concentrated, purified by S200 SEC and stored at −20 °C after dialysis into SEC buffer supplemented with 50% glycerol. p-CD3γ CD was cleared of Lck by acetone precipitation as described above and then subjected to SEC on a Superdex Peptide column. p-CD3γ CD was acetone precipitated and stored at −20 °C. cys p-CD3γ CD was cleared of Lck by acetone precipitation and Superdex Peptide SEC into PBS buffer. cys p-CD3γ CD -containing fractions were biotinylated at 0.6 mg/ml by overnight incubation at 4 °C with 350 µg/ml EZ Link Maleimide-PEG 2 -Biotin (Thermo Scientific) ( Supplementary Fig. 4 ). All expression constructs are listed in Supplementary Table 4. HDX-MS analysis. HDX-MS procedures for Zap70 study. HDX-MS samples were prepared from Zap70 50% glycerol stocks by S200 SEC purification into HDX-MS buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 0.25 mM TCEP, 1% glycerol, 0.1% octyl-β-D-glucopyranoside, 0.1 mM Na 3 VO 4 ). Monomeric peak fractions were concentrated to 3 mg/ml. We prepared Zap70-p-ITAM complex samples by incubating Zap70 with a 10-20-fold molar excess of p-CD3γ CD or the p-ITAM peptides overnight at 4 °C. Samples were filtered through a 0.1-µm filter before HDX-MS analysis on a Waters nanoACQUITY UPLC with HDX technology and Synapt G2 (Waters, Milford, MA, USA) as follows. Protein aliquots were mixed with an 11-fold excess of D 2 O (containing 0.1× PBS) and incubated at 8 °C for various amounts of time (10 s, 2 min, 5 min, 10 min, 1 h and 4 h). The exchange reactions were quenched for 2 min at 1 °C with an equal volume of 320 mM TCEP, 100 mM phosphate (pH 2.5). Quenched samples were immediately injected into a 50-µl sample loop and then subjected to digestion in an in-line pepsin column (Applied Biosystems, Poroszyme immobilized pepsin cartridge) at 15 °C with 0.2% formic acid at 100 µl/min for 2 min. The resulting peptic peptides were trapped with a Vanguard trap column at 0.5 °C, separated by an analytical column (Waters, Acquity UPLC BEH C18, 1.7 µm, 1.0 × 50 mm) at 0.5 °C with a gradient of 3%-85% acetonitrile (with 0.2% formic acid) over 10 min, and directed into a SYNAPT G2 mass spectrometer. The Synapt G2 was calibrated with Glufibrinopeptide before use. Mass spectra were acquired over the m/z range of 255-1,950 in ESI+, MS E mode with a lock mass m/z of 556.2771 from leucine enkephalin. We identified peptides with ProteinLynx Global Server 2.5 (Waters) using a combination of accurate mass and fragmental ions and imported the resulting peptide list into DynamX 2.0, where the MS E files of various time points were processed on the basis of the centroids of the MS mass spectra for relative deuterium incorporation.
HDX-MS data analyses for Zap70. We collected data for ~150 peptides per exchange reaction resulting in 96.5% sequence coverage ( Supplementary  Fig. 7 ). HDX-MS was done with kinase-dead YY DN to avoid unspecific background phosphorylation (Supplementary Fig. 4b) . Peptides with increased, reduced or unchanged deuterium uptake relative to Zap70 D461N (YY DN ) were detected in different Zap70 domains after association with p-CD3γ CD or the p-ITAM peptides of the CD3 subunits, as well as after phosphorylation by Lck and/or mutation of I-B tyrosine residues (Fig. 1b-e) . Maximal HDX differences were observed with 2 min of D 2 O incubation. Therefore, in subsequent analyses we focused on this time point. All data were normalized to the exchange of corresponding peptides from the autoinhibited YY DN . Changes in deuterium uptake were assigned to the smallest possible amino acid sequences and differences projected onto the known autoinhibited structure for YY DN (Fig. 2 and Supplementary Fig. 4) . Sixteen HDX-MS data sets for different states and mutants of Zap70 are compared by sequence alignment in Supplementary Figure 2 , and seven HDX-MS data sets comparing the effects of different p-ITAM peptide bindings are shown in Figure 3d . Peptide regions with changes in deuterium uptake were colored on the structures of YY DN (4K2R) 17 , tSH2 (1M61) 42 , KinD (1U59) 33 and tSH2 cplx (2OQ1) 12 with the UCSF Chimera Software. Zap70 models were prepared in Adobe Illustrator, and amino acids not resolved in the structures were added as unstructured chains of dots colored according to the deuterium changes in those regions.
ELISA-based protein-concentration adjustment. We estimated protein stock concentrations by measuring absorbance at 280 nm and correcting the concentrations. We achieved rough verification of these values by running 1 µg of stock (predicted from the A 280 ) on a Coomassie-stained SDS-PAGE gel and comparing it to a known standard. On the basis of these assessments, we prepared twofold dilutions ranging from 1 µg/ml to 7.5 ng/ml in 50 mM Na 2 CO 3 , pH 9.2, and used 50 µl of each to coat duplicate wells of Immulon 4HBX plates. We allowed proteins to adsorb at room temperature for 1 h, at which time we removed unbound protein by washing wells with TBS + 0.05% Tween-20 (TBST). Next the antigen-coated wells were blocked for 1 h at room temperature with 1% BSA in TBST. Adsorbed proteins were subsequently detected with 1 µg/ml anti-Zap70 clone 29 (BD Biosciences, 610240) to detect the C terminus or with clone 2F3.2 (Upstate, 05-253) to detect the N terminus. Detection antibodies were incubated for 1 h at room temperature in 0.5% BSA in TBST with agitation. Wells were subsequently washed with TBST and then detected with 0.8 µg/ml HRP-labeled goat anti-mouse (ThermoPierce, 31436) for 30 min. Wells were washed again with TBST, and then bound detection antibody was visualized colorimetrically with Fast-OPD (Sigma); color development was stopped with 3N HCl according to the manufacturer's instructions. Absorbance at 490 nm was determined, and concentrations were corrected on the basis of comparison of multiple points in the linear portion of the curves. We corrected new protein lots using the Myc-tagged preparations as a standard.
Activation of stable Zap70-expressing Jurkat T cells. Stable Jurkat cell lines (gifts from A. Weiss (University of California San Francisco); tested for mycoplasma contamination) expressing Zap70-GFP fusion protein were prepared by lentiviral infection. We prepared the virus by seeding HEK293T cells (a gift from M.M. Davis (Stanford University); tested for mycoplasma contamination) at 8 × 10 6 cells per 10 cm dish one day before transfection. One hour before transfection, we replaced the growth media (DMEM, 10% FCS) with Opti-MEM (Life Technologies). Cells were transfected with 7 µg transfer vector and 2.6 µg pVSVG, 2.13 µg pRSV/REV and 5.2 µg pMDL.G (RRE) packaging vectors in 1.5 ml Opti-MEM. Lipofectamine 2000 (5 µl/µg of DNA) was added to 1.5 ml Opti-MEM and incubated for 5 min at room temperature. Subsequently, we added the DNA-Opti-MEM mix, mixed the samples by vortexing and incubated the mixture for 20 min at room temperature. DNA-Lipofectamine 2000 mix (3 ml) was added dropwise to the cells, after which they were incubated for 6 h (37 °C, 5% CO 2 ). Subsequently, the media was exchanged for DMEM, 10% FCS supplemented with 25 mM HEPES, pH 7.4, and cells were incubated for 40 h (37 °C, 5% CO 2 ). We recovered virus by removing cells from the media (centrifugation at 1,000 rpm for 10 min and filtering through a 0.45-µm polyethersulfone filter). We prepared stable Jurkat P116 cell lines by infecting 7.5 × 10 5 Jurkat P116 cells with 1.4 ml virus per well that had been preincubated with 8 µg/ml Polybrene (Millipore) for 20 min. After Jurkat P116 cells (0.1 ml at 7.5 × 10 6 cells/ml) had been added to the virus, the mixture was centrifuged at 1,500 rpm for 1 h at room temperature, after which the media was replaced with 1 ml of RPMI 1640 medium + 5% FBS and incubated at 37 °C for 4 h. Cells were split 1:4 and then incubated overnight. 48 h after infection, we selected cells via the addition of 0.75 µg/ml Puromycin (BioWorld) for 48 h. After selection, dead cells were removed by Ficoll-Paque PLUS (GE Healthcare), and live cells were kept in RPMI1 1640 medium + 5% FCS supplemented with 0.1 µg/ml puromycin.
For Jurkat activation, 2× preparations of activating crosslinked antibody solutions were prepared as follows: OKT3 (eBioscience, 16-0037) and OKT4 (BioXCell, BE0003-2) were diluted to 10 µg/ml in PBS 2+ (PBS containing 2 mM CaCl 2 and 2 mM MgCl 2 ), and then secondary F C -specific goat antimouse (Pierce, 31168) was added to a final concentration of 40 µg/ml. The solution was incubated for 30 min at room temperature to facilitate maximal crosslinking before serial twofold dilution of the mixture in PBS 2+ . Stable P116 cell lines were pelleted and washed once with PBS 2+ before being resuspended in PBS 2+ at 1.2 × 10 8 cells per milliliter. Cells (25 µl per condition) were added to an equal volume of activating antibody solution, and tubes were incubated at 37 °C for 2 min before rapid pelleting of cells and removal of supernatant. 
